Tumor News and Research

RSS

New analysis highlights increasing focus of early-stage clinical trials on rare cancers

The proportion of early-stage drug trials tackling the biggest cancer killers has declined sharply since the early 1990s as less common tumor types receive increasing attention, according to new research to be presented during the International Congress on Targeted Anticancer Therapies 2019, taking place from today to 27 February in Paris, France.

25 Feb 2019

Researchers engineer 'antibody-like' T cell receptors to combat deadly virus

Researchers have engineered "antibody-like" T cell receptors that can specifically stick to cells infected with cytomegalovirus, or CMV, a virus that causes lifelong infection in more than half of all adults by age 40.

23 Feb 2019

Researchers find increased rates of CRC screening in Kentucky after Medicaid expansion

Kentucky is one of the poorest states in the U.S. However, the state has been one of the most successful in reducing its uninsured rate, which happened in part through the Affordable Care Act's Medicaid expansion that took effect on January 1, 2014.

23 Feb 2019

New technology platform digitally counts growth factors in single cells

Whether healthy or diseased, human cells exhibit behaviors and processes that are largely dictated by growth factor molecules, which bind to receptors on the cells. For example, growth factors tell the cells to divide, move, and when to die--a process known as apoptosis.

23 Feb 2019

CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center today was awarded $19.6 million from the Cancer Prevention and Research Institute of Texas (CPRIT) to support research, recruitment and prevention efforts.

22 Feb 2019

Study finds out similarity in function between healthy retina cell and tumor cell

How is a healthy retina cell like a tumor cell? It hijacks an energy-producing chemical reaction to churn out molecular building blocks. When tumor cells do it, they use the building blocks to make cancer grow and spread. But when retina cells do it, they renew photoreceptor membranes that keep our vision sharp.

22 Feb 2019

Akna protein plays a key role in the regulation of neural stem cells

The use of stem cells to repair organs is one of the foremost goals of modern regenerative medicine.

22 Feb 2019

New design guidance could advance development of disease-sensing nanomaterials

Scientists have long sought to develop drug therapies that can more precisely diagnose, target and effectively treat life-threatening illness such as cancer, cardiovascular and autoimmune diseases.

22 Feb 2019

New study finds how high-fat diets fuel colorectal cancer growth

As cancer death rates drop overall, doctors have noted a frightening anomaly: deaths from colorectal cancer in people under 55 appear to be creeping up. According to the American Cancer Society, deaths in this younger group increased by 1 percent between 2007 and 2016.

22 Feb 2019

New identified biomarker predicts patients who might benefit from HER2-targeted agents

In an effort to further individualize therapy and avoid over-treating patients, researchers at the Johns Hopkins Kimmel Cancer Center report a new study using PET scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chemotherapy.

22 Feb 2019

Study: Cancer stem-like cells are maintained by MTHFD2 mitochondrial metabolic enzyme

An increase in the incidence and mortality rate of cancer has been noted worldwide, especially for lung cancer.

22 Feb 2019

Scientists uncover new mechanisms regulating neural stem cells

The use of stem cells to repair organs is one of the foremost goals of modern regenerative medicine. Scientists at Helmholtz Zentrum München and Ludwig Maximilian University of Munich have discovered that the protein Akna plays a key role in this process.

21 Feb 2019

PENTAX Medical introduces new electrosurgical and argon plasma coagulation platforms

PENTAX Medical announces the addition of new dedicated electrosurgical and argon plasma coagulation platforms – the ENDO ARC and ENDO PLUS – to its therapeutic accessories range.

From PENTAX Medical Company 21 Feb 2019

Why melanoma tumors in the brain may be worse?

Melanoma tumors that have spread to the brain are equipped to thwart immunotherapies and targeted therapies that succeed against tumors growing in other sites.

20 Feb 2019

Penn study reveals increase in health-related internet searches before ER visits

Health-related internet searches doubled during the week before patients visited an emergency department, according to a new study from researchers at Penn Medicine who examined consenting patients' Google search histories in relation to their electronic health records.

20 Feb 2019

Immunotherapeutic antibody therapy to kill cancer has now progressed to patient testing

Developed by researchers at the University of Turku in Finland, an immunotherapeutic antibody therapy re-educates macrophages to activate passivated cytotoxic T cells to kill cancer. The antibody therapy prevented the growth of tumors in several mouse models.

20 Feb 2019

New forms of older anti-cancer agent appear to enhance immune response to fight melanoma

Researchers at the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and the Johns Hopkins University School of Medicine report two new forms of an older anti-cancer agent they developed appear to enhance the immune system's ability to fight melanoma in mice.

20 Feb 2019

Tumor News and Research

New analysis highlights increasing focus of early-stage clinical trials on rare cancers

Researchers engineer 'antibody-like' T cell receptors to combat deadly virus

Researchers find increased rates of CRC screening in Kentucky after Medicaid expansion

New technology platform digitally counts growth factors in single cells

CPRIT awards nearly $20 million to The University of Texas MD Anderson Cancer Center

Study finds out similarity in function between healthy retina cell and tumor cell

Akna protein plays a key role in the regulation of neural stem cells

New design guidance could advance development of disease-sensing nanomaterials

New study finds how high-fat diets fuel colorectal cancer growth

New identified biomarker predicts patients who might benefit from HER2-targeted agents

Study: Cancer stem-like cells are maintained by MTHFD2 mitochondrial metabolic enzyme

Scientists uncover new mechanisms regulating neural stem cells

PENTAX Medical introduces new electrosurgical and argon plasma coagulation platforms

Why melanoma tumors in the brain may be worse?

Penn study reveals increase in health-related internet searches before ER visits

Immunotherapeutic antibody therapy to kill cancer has now progressed to patient testing

New forms of older anti-cancer agent appear to enhance immune response to fight melanoma

Study suggests new treatment strategy for deadly brain cancer

First molecular test predicts treatment response for kidney cancer

New study establishes how stress favors breast cancer growth and spread

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News